Risk factors for surgical site infection and association of surgical site infection with survival of lower rectal cancer patients without clinical lateral pelvic lymph node metastasis (clinical Stage II/III): Analysis of data from JCOG0212

被引:0
作者
Kenji Katsumata
Masanobu Enomoto
Tetsuo Ishizaki
Shin Fujita
Yukihide Kanemitsu
Masaaki Ito
Akio Shiomi
Koji Komori
Masayuki Ohue
Mitsuyoshi Ota
Yoshihiro Akazai
Manabu Shiozawa
Takashi Yamaguchi
Hiroyuki Bando
Mitugu Sekimoto
Takaya Kobatake
Ryunosuke Machida
Takayuki Akasu
Yoshihiro Moriya
机构
[1] Tokyo Medical University,Department of Gastrointestinal and Pediatric Surgery
[2] Tochigi Cancer Center,Department of Surgery
[3] National Cancer Center Hospital,Department of Colorectal Surgery
[4] National Cancer Center Hospital East,Department of Colorectal Surgery
[5] Shizuoka Cancer Center Hospital,Division of Colon and Rectal Surgery
[6] Aichi Cancer Center Hospital,Department of Surgery
[7] Osaka International Cancer Institute,Department of Gastroenterological Surgery
[8] Yokohama City University Medical Center,Department of Surgery
[9] Okayama Saiseikai General Hospital,Department of Surgery
[10] Kanagawa Cancer Center,Department of Surgery
[11] Kyoto Medical Center,Department of Surgery
[12] Ishikawa Prefectural Central Hospital,Department of Surgery
[13] National Hospital Organization Osaka National Hospital,Department of Surgery
[14] Shikoku Cancer Center,Department of Surgery
[15] National Cancer Center Hospital,JCOG Data Center and Operations Office
[16] The Imperial Household Agency Hospital,Department of Surgery
[17] Japanese Red Cross Medical Center,Department of Surgery
来源
Clinical & Experimental Metastasis | 2021年 / 38卷
关键词
Rectal cancer; Latera lymph node dissection; Surgical site infection; Recurrence;
D O I
暂无
中图分类号
学科分类号
摘要
This study aimed to examine the risk factors for surgical site infection (SSI) and the association of that with recurrence in JCOG0212. The results for secondary endpoints showed that compared with the mesorectal excision (ME) alone group, ME with lateral lymph node dissection (LLND) group showed significantly longer operative time and significantly higher blood loss. These results suggested that LLND was a risk factor for SSI. All 701 patients registered in JCOG0212 were analyzed in this study. Wound infection was defined as incisional/deep SSI, and pelvic abscess and anastomotic leakage were defined as organ/space SSI. The risk factors for the incidence of SSI and the effect of SSI on relapse-free survival (RFS) were investigated. Multivariable odds ratio of Grade 2 or higher all SSI was 0.58 [95% Confidence interval: 0.36–0.93] for female (vs. male) and that of Grade 2 or higher incisional/deep SSI was 2.24 [1.03–4.86] for blood infusion. For RFS, patients with Grade 3 or higher all SSI showed poor prognosis (multivariable hazard ratio: 1.66 [1.03–2.68]). LLND is not significant factor for the incidence of all SSI. Male sex might be a risk factor of Grade 2 or higher SSI, and blood transfusion is a possible risk factor of Grade 2 or higher incisional/deep SSI. Grade 3 or higher all SSI might be a significant worse prognostic factor for lower rectal cancer.
引用
收藏
页码:459 / 466
页数:7
相关论文
共 45 条
[1]  
Allegranzi B(2011)Burden of endemic health-care associated infection in developing countries: systematic review and meta-analysis Lancet 377 228-241
[2]  
Bagheri NS(2005)Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer Br J Surg 92 756-763
[3]  
Combescure C(2006)Indication and benefit of pelvic sidewall dissection for rectal cancer Dis Colon Rectum 49 1663-1672
[4]  
Ueno M(2016)The impact of postoperative complications on long-term oncologic outcomes after laparoscopic low anterior resection for rectal cancer Medicine 95 e3271-34
[5]  
Oya M(2018)Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer Int J Clin Oncol 23 1-1232
[6]  
Azekura K(1995)Nerve-sparing surgery with lateral node dissection for advanced lower rectal cancer Eur J Cancer 31 1229-207
[7]  
Sugihara K(2017)Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial Ann Surg 266 201-621
[8]  
Kobayashi H(2012)Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical Stage II or Stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial Lancet Oncol 13 616-594
[9]  
Kato T(2019)Parallel-group controlled trial of esophagectomy versus chemoradiotherapy in patients with clinical Stage I esophageal carcinoma (JCOG0502)JCOG 0502 J Clin Oncol 37 7-214
[10]  
Park EJ(2009)Current perioperative practice in patients with colorectal surgery: results of a questionnaire survey in Japan J Jpn Soc Surg Infect 6 587-302